662 related articles for article (PubMed ID: 34631874)
1. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of an m
Li H; Jiang H; Huang Z; Chen Z; Chen N
Cancer Manag Res; 2021; 13():6673-6687. PubMed ID: 34471382
[TBL] [Abstract][Full Text] [Related]
3. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
Zhang L; Su Z; Hong F; Wang L
Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
[TBL] [Abstract][Full Text] [Related]
5. Identification of a m
Chen J; Yu K; Zhong G; Shen W
Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
[TBL] [Abstract][Full Text] [Related]
6. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma.
Chen Y; Hu W; Wei X; Zhang L; Shao Y; Tian J; Wang D; Wu B
Transl Androl Urol; 2023 Apr; 12(4):622-641. PubMed ID: 37181235
[TBL] [Abstract][Full Text] [Related]
8. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL]